Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1 (Q92471802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

title

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Christina Nicolodi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

Franz Groiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

Oleg Kiselev

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

Markus Wolschek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

Thomas Muster

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

publication date

30 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

3722-3729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Probable person-to-person transmission of avian influenza A (H5N1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Three Indonesian clusters of H5N1 virus infection in 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

The role of nasal IgA in children vaccinated with live attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

A DNA transfection system for generation of influenza A virus from eight plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Recognizing true H5N1 infections in humans during confirmed outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Live attenuated versus inactivated influenza vaccine in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Genotypic characterization and clinical evaluation of an influenza A/Texas/1/77 (H3N2)-like recombinant: RIT 4199

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Erythrocyte binding preference of avian influenza H5N1 viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1016/J.VACCINE.2019.05.013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31155415 AND SRC:MED&resulttype=core&format=json

29 April 2020

1 reference